PortfoliosLab logoPortfoliosLab logo
BMED vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BMED vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Future Health ETF (BMED) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BMED achieves a -5.19% return, which is significantly lower than XLVI's 1.35% return.


BMED

1D
1.98%
1M
2.19%
YTD
-5.19%
6M
-5.93%
1Y
17.59%
3Y*
5.91%
5Y*
-0.08%
10Y*

XLVI

1D
2.03%
1M
4.01%
YTD
1.35%
6M
3.19%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BMED vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between BMED and XLVI is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.78

BMED vs. XLVI - Sectors Allocation Comparison


Sectors
BMED
XLVI

Healthcare

100.0%

-

Consumer Defensive

1.5%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Financial Services

-

100.6%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

BMED
100.0%
XLVI

-

Consumer Defensive

BMED
1.5%
XLVI

-

Basic Materials

BMED

-

XLVI

-

Communication Services

BMED

-

XLVI

-

Consumer Cyclical

BMED

-

XLVI

-

Energy

BMED

-

XLVI

-

Financial Services

BMED

-

XLVI
100.6%

Industrials

BMED

-

XLVI

-

Real Estate

BMED

-

XLVI

-

Technology

BMED

-

XLVI

-

Utilities

BMED

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BMED vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMED
BMED Risk / Return Rank: 2929
Overall Rank
BMED Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
BMED Sortino Ratio Rank: 3333
Sortino Ratio Rank
BMED Omega Ratio Rank: 3131
Omega Ratio Rank
BMED Calmar Ratio Rank: 2626
Calmar Ratio Rank
BMED Martin Ratio Rank: 2424
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMED vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BMEDXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.20

Calmar ratioReturn relative to maximum drawdown

1.19

Martin ratioReturn relative to average drawdown

3.00

BMED vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


BMEDXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.00

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

1.54

-1.42

Drawdowns

BMED vs. XLVI - Drawdown Comparison

The maximum BMED drawdown since its inception was -36.44%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for BMED and XLVI.


Loading charts...

Drawdown Indicators


BMEDXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-36.44%

-8.14%

-28.30%

Max Drawdown (1Y)

Largest decline over 1 year

-14.85%

Max Drawdown (3Y)

Largest decline over 3 years

-20.12%

Max Drawdown (5Y)

Largest decline over 5 years

-33.90%

Current Drawdown

Current decline from peak

-11.17%

-2.08%

-9.09%

Average Drawdown

Average peak-to-trough decline

-19.08%

-1.95%

-17.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.88%

Volatility

BMED vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


BMEDXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.74%

Volatility (6M)

Calculated over the trailing 6-month period

11.23%

Volatility (1Y)

Calculated over the trailing 1-year period

15.23%

11.12%

+4.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.43%

11.12%

+6.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.77%

11.12%

+6.65%

BMED vs. XLVI - Expense Ratio Comparison

BMED has a 0.85% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

BMED vs. XLVI - Dividend Comparison

BMED has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.30%.


PositionTTM202520242023
BMED
Future Health ETF
0.00%0.00%0.00%0.03%
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.30%5.73%0.00%0.00%

Frequently Asked Questions


BMED and XLVI have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.85% for BMED.

XLVI has the higher dividend yield at 11.30%, compared with 0.00% for BMED.

BMED is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: BlackRock and State Street. Their fees differ too: 0.85% for BMED and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for BMED and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer